HIF alpha expression in VHL-deficient renal cancer cells is dependent on phospholipase D. (Q40052813)

16 September 2017

title

HIF alpha expression in VHL-deficient renal cancer cells is dependent on phospholipase D. (English)

1 reference

16 September 2017

A Toschi

1

1 reference

16 September 2017

J Edelstein

2

1 reference

16 September 2017

P Rockwell

3

1 reference

16 September 2017

M Ohh

4

1 reference

16 September 2017

D A Foster

5

1 reference

16 September 2017

language of work or name

English

0 references

publication date

12 November 2007

1 reference

16 September 2017

1 reference

16 September 2017

volume

27

1 reference

16 September 2017

issue

19

1 reference

16 September 2017

page(s)

2746-2753

1 reference

PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Alternative phospholipase D/mTOR survival signal in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Phospholipase D confers rapamycin resistance in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Phosphatidic acid-mediated mitogenic activation of mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Targeting mTOR-mediated survival signals in anticancer therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Regulation of mTOR by phosphatidic acid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Why do cancers have high aerobic glycolysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Hypoxia-inducible factors: central regulators of the tumor phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Regulation of angiogenesis by hypoxia and hypoxia-inducible factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

mTOR-dependent suppression of protein phosphatase 2A is critical for phospholipase D survival signals in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

The HIF pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Ubiquitin pathway in VHL cancer syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Phospholipase D and its product, phosphatidic acid, mediate agonist-dependent raf-1 translocation to the plasma membrane and the activation of the mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Myc stabilization in response to estrogen and phospholipase D in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Will mTOR inhibitors make it as cancer drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

HIF-1 and mechanisms of hypoxia sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Glucose metabolism and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Role for phospholipase D in receptor-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Molecular analysis of mammalian phospholipase D2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Mutagenesis of phospholipase D defines a superfamily including a trans-Golgi viral protein required for poxvirus pathogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Phospholipase D couples survival and migration signals in stress response of human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Phospholipase D prevents apoptosis in v-Src-transformed rat fibroblasts and MDA-MB-231 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

Targeting Phospholipase D-mediated Survival Signals in Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

inferred from DOI database lookup

7 January 2021

based on heuristic

Increased activity and intranuclear expression of phospholipase D2 in human renal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210927

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1210927

1 reference

Dimensions Publication ID

16 September 2017

1010104642

0 references

1 reference